IT1147806B - Complessi di ciclodestrine e glicosidi cardiaci per uso terapeutico e procedimento di preparazione - Google Patents
Complessi di ciclodestrine e glicosidi cardiaci per uso terapeutico e procedimento di preparazioneInfo
- Publication number
- IT1147806B IT1147806B IT47635/82A IT4763582A IT1147806B IT 1147806 B IT1147806 B IT 1147806B IT 47635/82 A IT47635/82 A IT 47635/82A IT 4763582 A IT4763582 A IT 4763582A IT 1147806 B IT1147806 B IT 1147806B
- Authority
- IT
- Italy
- Prior art keywords
- cyclodestrine
- complexes
- therapeutic use
- preparation procedure
- cardiac glycosides
- Prior art date
Links
- 229940097217 cardiac glycoside Drugs 0.000 title 1
- 239000002368 cardiac glycoside Substances 0.000 title 1
- 229930002534 steroid glycoside Natural products 0.000 title 1
- 150000008143 steroidal glycosides Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8102124 | 1981-01-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8247635A0 IT8247635A0 (it) | 1982-01-22 |
| IT1147806B true IT1147806B (it) | 1986-11-26 |
Family
ID=10519177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT47635/82A IT1147806B (it) | 1981-01-23 | 1982-01-22 | Complessi di ciclodestrine e glicosidi cardiaci per uso terapeutico e procedimento di preparazione |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4555504A (it) |
| EP (1) | EP0056995B1 (it) |
| JP (1) | JPS57182301A (it) |
| AU (1) | AU558787B2 (it) |
| CA (1) | CA1222742A (it) |
| DE (1) | DE3270055D1 (it) |
| IE (1) | IE52500B1 (it) |
| IT (1) | IT1147806B (it) |
| NZ (1) | NZ199543A (it) |
| ZA (1) | ZA82447B (it) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3372705D1 (en) * | 1982-04-30 | 1987-09-03 | Takeda Chemical Industries Ltd | Pharmaceutical composition and its use |
| US4675395A (en) * | 1984-03-14 | 1987-06-23 | Seiwa Technological Laboratories Limited | Cyclodextrin inclusion compound and process for its preparation |
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4764601A (en) * | 1985-10-18 | 1988-08-16 | The Ohio State University Research Foundation | Composition for assaying cardiac glycosides from serum or plasma |
| JPS6333341A (ja) * | 1986-07-28 | 1988-02-13 | Seitetsu Kagaku Co Ltd | 配糖体の処理方法 |
| US4798804A (en) * | 1987-02-05 | 1989-01-17 | Syntex (U.S.A.) Inc. | Serum pretreatment in digoxin immunoassay |
| HU201685B (en) * | 1987-04-23 | 1990-12-28 | Chinoin Gyogyszer Es Vegyeszet | For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition |
| US4840679A (en) * | 1987-07-08 | 1989-06-20 | American Maize-Products Company | Purification and separation of branched beta-cyclodextrins |
| US5017566A (en) * | 1987-12-30 | 1991-05-21 | University Of Florida | Redox systems for brain-targeted drug delivery |
| US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
| SI8810082A8 (en) * | 1988-01-18 | 1995-12-31 | Lek Tovarna Farmacevtskih | Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine |
| US5223295A (en) * | 1988-01-22 | 1993-06-29 | Asterol International | Process for the elimination of steroid compounds contained in substance of biological origin |
| EP0381747A4 (en) * | 1988-08-15 | 1991-09-11 | American Maize-Products Company | Water soluble branched beta cyclodextrin steroid complex |
| US5229370A (en) * | 1988-08-15 | 1993-07-20 | Ammeraal Robert N | Water soluble branched beta cyclodextrin steroid complex |
| US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| US5703088A (en) * | 1989-08-21 | 1997-12-30 | Beth Israel Deaconess Medical Center, Inc. | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| EP0520032B1 (en) * | 1990-03-16 | 1998-09-16 | Beth Israel Hospital Association | Use of spiperone as an immunosuppressant and anti-inflammatory agent |
| US5574041A (en) * | 1990-03-16 | 1996-11-12 | Beth Israel Hospital Association | Use of spiperone derivatives as immunosuppressant agents |
| US5602112A (en) * | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
| US20040014695A1 (en) * | 1992-06-19 | 2004-01-22 | Supergen, Inc. | Pharmaceutical formulation |
| US5693645A (en) * | 1992-12-23 | 1997-12-02 | Beth Israel Deaconess Medical Center, Inc. | Use of spiperone or spiperone derivatives as immunosuppressant agents |
| US5362860A (en) * | 1993-02-01 | 1994-11-08 | Warner-Lambert Company | Neutral stabilization complex for CI-979 HCl, a cognition activator |
| US5658390A (en) * | 1994-06-29 | 1997-08-19 | American Maize-Products Company | Purification of beta cyclodextrin |
| US5824668A (en) * | 1996-11-07 | 1998-10-20 | Supergen, Inc. | Formulation for administration of steroid compounds |
| US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
| US6962944B2 (en) | 2001-07-31 | 2005-11-08 | Arqule, Inc. | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| US7074824B2 (en) * | 2001-07-31 | 2006-07-11 | Arqule, Inc. | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| WO2004087121A2 (en) * | 2003-03-28 | 2004-10-14 | Azaya Therapeutics, Inc. | Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| US20060205679A1 (en) * | 2004-10-22 | 2006-09-14 | Azaya Therapeutics, Inc. | Topical and oral formulations of cardiac glycosides for treating skin diseases |
| US20070009532A1 (en) * | 2005-07-06 | 2007-01-11 | Branimir Sikic | Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| US20070010487A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| US20070010486A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| US20070010466A1 (en) * | 2005-07-06 | 2007-01-11 | Branimir Sikic | Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer |
| US20070010485A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
| WO2010017480A1 (en) * | 2008-08-07 | 2010-02-11 | Centrose, Llc | Glycoside compounds and pharmaceutical compositions thereof |
| CA2809819A1 (en) | 2009-09-09 | 2011-03-17 | Centrose, Llc | Extracellular targeted drug conjugates |
| MY161487A (en) * | 2010-02-08 | 2017-04-14 | Coca Cola Co | Solubility enhanced terpene glycoside(s) |
| US9480755B2 (en) * | 2011-06-03 | 2016-11-01 | Ratiopharm Gmbh | Pharmaceutical composition comprising dapagliflozin and cyclodextrin |
| CA3012837A1 (en) | 2016-02-04 | 2017-08-10 | Czap Research And Development, Llc | Controlled-release and stratified cyclodextrin inclusion complex vehicles |
| WO2021191803A1 (en) | 2020-03-23 | 2021-09-30 | Czap Research And Development, Llc | Oral terpene cyclodextrin inclusion complex vehicles |
| CN116236442B (zh) * | 2023-03-20 | 2025-05-02 | 湖北民康药业集团有限公司 | 地高辛注射液及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE513723A (it) * | 1900-01-01 | |||
| DE895769C (de) * | 1951-08-26 | 1953-11-05 | Knoll Ag | Verfahren zur Herstellung von Einschlussverbindungen physiologisch wirksamer organischer Verbindungen |
| US3541077A (en) * | 1968-05-31 | 1970-11-17 | Cpc International Inc | Method of preparing pure alpha-cyclodextrin |
| JPS50160416A (it) * | 1974-06-24 | 1975-12-25 | ||
| JPS51118817A (en) * | 1975-04-08 | 1976-10-19 | Nippon Shinyaku Co Ltd | A process for preparing absorbable steroid glycoside pharmaceutical |
| JPS5762297A (en) * | 1980-10-01 | 1982-04-15 | Mitsubishi Yuka Yakuhin Kk | Digitalis cardiac glycoside-cyclodextrin inclusion compound |
-
1982
- 1982-01-22 DE DE8282100450T patent/DE3270055D1/de not_active Expired
- 1982-01-22 IE IE136/82A patent/IE52500B1/en unknown
- 1982-01-22 CA CA000394744A patent/CA1222742A/en not_active Expired
- 1982-01-22 EP EP82100450A patent/EP0056995B1/en not_active Expired
- 1982-01-22 JP JP57008737A patent/JPS57182301A/ja active Pending
- 1982-01-22 NZ NZ199543A patent/NZ199543A/en unknown
- 1982-01-22 ZA ZA82447A patent/ZA82447B/xx unknown
- 1982-01-22 AU AU79734/82A patent/AU558787B2/en not_active Ceased
- 1982-01-22 IT IT47635/82A patent/IT1147806B/it active
-
1984
- 1984-03-12 US US06/589,035 patent/US4555504A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IE820136L (en) | 1982-07-23 |
| DE3270055D1 (en) | 1986-04-30 |
| IE52500B1 (en) | 1987-11-25 |
| EP0056995A1 (en) | 1982-08-04 |
| US4555504A (en) | 1985-11-26 |
| AU558787B2 (en) | 1987-02-12 |
| IT8247635A0 (it) | 1982-01-22 |
| JPS57182301A (en) | 1982-11-10 |
| AU7973482A (en) | 1982-07-29 |
| ZA82447B (en) | 1983-09-28 |
| NZ199543A (en) | 1985-04-30 |
| CA1222742A (en) | 1987-06-09 |
| EP0056995B1 (en) | 1986-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1147806B (it) | Complessi di ciclodestrine e glicosidi cardiaci per uso terapeutico e procedimento di preparazione | |
| NZ190923A (en) | Platinum diamine complexes medical preparations | |
| GB8401486D0 (en) | Diagnostic preparations | |
| KR880701554A (ko) | 스테로이드제 함유 외용 첩부제 | |
| IT1163001B (it) | Procedimento per la preparazione di 4' epidaunorubicina 3', 4' diepidaunorubicina e corrispondenti analoghi della doxorubicina | |
| CU35257A (en) | Flavone derivatives its preparation procedure and pharmaceutical agents | |
| DK164018C (da) | Retinolholdigt praeparat til hudpleje | |
| DK565089A (da) | Hudpraeparater | |
| IT1153294B (it) | Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle | |
| IT1193421B (it) | Preparati terapeutici antimicotici in crema o pomata | |
| DK489587D0 (da) | Medicinsk hudpraeparat | |
| IT8621294A0 (it) | Procedimento di preparazione di monosialoganglioside. | |
| DK394084D0 (da) | Fysiologisk aktive praeparater | |
| DK5587D0 (da) | Bestraalingsanordning til medicinsk anvendelse | |
| DK194981A (da) | Hudpraeparat | |
| IT1156478B (it) | Procedimento per la preparazione di acril e metacril ammidi | |
| IT1130076B (it) | Procedimento per la preparazione di solfossidi di penicellina | |
| IT1170862B (it) | Mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico | |
| IT1223408B (it) | Procedimento per la preparazione di monosialoganglioside | |
| IT8224456A0 (it) | Prostacicline e procedimento per laloro preparazione | |
| IT1143906B (it) | Tiocarnitine procedimento per la loro preparazione e loro uso terapeutico | |
| IT1198416B (it) | Procedimento di preparazione di mononitroclorobenzene | |
| JPS54135486A (en) | Medical chair | |
| IT1168940B (it) | Preparazioni farmaceutiche per uso anticataratta | |
| IT1168941B (it) | Preparazioni farmaceutiche per uso anticatarrata |